 | • レポートコード：D0804-02481 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、化学療法誘発性悪心嘔吐（CINV）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。化学療法誘発性悪心嘔吐（CINV）薬の種類別市場規模（アロキシ（パロノセトロン）、キトリルジェネリック（グラニセトロン）、エメンド（アプレピタント）、アキンゼオ（ネトピタント-パロノセトロン））、用途別市場規模（血液がん、乳がん、消化管がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Barr Laboratories、Merck & Co、Helsinn、Aphios、Heron Therapeutics、Eisai、Acacia Pharma、Tesaro、Baxter Healthcare、OPKO Health、Especificos Stendhal、Orchid Healthcare、Mylan Pharmaceuticals、F.Hoffmann La Roche、Mundipharma ・地域別グローバル市場分析 2015年-2020年 ・化学療法誘発性悪心嘔吐（CINV）薬の北米市場（アメリカ、カナダ、メキシコ） ・化学療法誘発性悪心嘔吐（CINV）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・化学療法誘発性悪心嘔吐（CINV）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・化学療法誘発性悪心嘔吐（CINV）薬の南米市場（ブラジル、アルゼンチン） ・化学療法誘発性悪心嘔吐（CINV）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アロキシ（パロノセトロン）、キトリルジェネリック（グラニセトロン）、エメンド（アプレピタント）、アキンゼオ（ネトピタント-パロノセトロン） ・用途別分析：血液がん、乳がん、消化管がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2301630 million by 2025, from USD 1835980 million in 2019.
The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market has been segmented into
Aloxi (palonosetron)
Kytril Generic (granisetron)
Emend (aprepitant)
Akynzeo (netupitant-palonosetron)
By Application, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs has been segmented into:
Blood Cancer
Breast Cancer
Gastrointestinal Tract Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Analysis
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs are:
GlaxoSmithKline
Barr Laboratories
Merck & Co
Helsinn
Aphios
Heron Therapeutics
Eisai
Acacia Pharma
Tesaro
Baxter Healthcare
OPKO Health
Especificos Stendhal
Orchid Healthcare
Mylan Pharmaceuticals
F.Hoffmann La Roche
Mundipharma
Among other players domestic and global, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with price, sales, revenue and global market share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in 2018 and 2019.
Chapter 3, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Aloxi (palonosetron)
1.2.3 Kytril Generic (granisetron)
1.2.4 Emend (aprepitant)
1.2.5 Akynzeo (netupitant-palonosetron)
1.3 Market Analysis by Application
1.3.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Tract Cancer
1.3.5 Others
1.4 Overview of Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Barr Laboratories
2.2.1 Barr Laboratories Details
2.2.2 Barr Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Barr Laboratories SWOT Analysis
2.2.4 Barr Laboratories Product and Services
2.2.5 Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co
2.3.1 Merck & Co Details
2.3.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck & Co SWOT Analysis
2.3.4 Merck & Co Product and Services
2.3.5 Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Helsinn
2.4.1 Helsinn Details
2.4.2 Helsinn Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Helsinn SWOT Analysis
2.4.4 Helsinn Product and Services
2.4.5 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aphios
2.5.1 Aphios Details
2.5.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aphios SWOT Analysis
2.5.4 Aphios Product and Services
2.5.5 Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Heron Therapeutics
2.6.1 Heron Therapeutics Details
2.6.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Heron Therapeutics SWOT Analysis
2.6.4 Heron Therapeutics Product and Services
2.6.5 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eisai
2.7.1 Eisai Details
2.7.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eisai SWOT Analysis
2.7.4 Eisai Product and Services
2.7.5 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Acacia Pharma
2.8.1 Acacia Pharma Details
2.8.2 Acacia Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Acacia Pharma SWOT Analysis
2.8.4 Acacia Pharma Product and Services
2.8.5 Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Tesaro
2.9.1 Tesaro Details
2.9.2 Tesaro Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Tesaro SWOT Analysis
2.9.4 Tesaro Product and Services
2.9.5 Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Baxter Healthcare
2.10.1 Baxter Healthcare Details
2.10.2 Baxter Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Baxter Healthcare SWOT Analysis
2.10.4 Baxter Healthcare Product and Services
2.10.5 Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 OPKO Health
2.11.1 OPKO Health Details
2.11.2 OPKO Health Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 OPKO Health SWOT Analysis
2.11.4 OPKO Health Product and Services
2.11.5 OPKO Health Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Especificos Stendhal
2.12.1 Especificos Stendhal Details
2.12.2 Especificos Stendhal Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Especificos Stendhal SWOT Analysis
2.12.4 Especificos Stendhal Product and Services
2.12.5 Especificos Stendhal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Orchid Healthcare
2.13.1 Orchid Healthcare Details
2.13.2 Orchid Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Orchid Healthcare SWOT Analysis
2.13.4 Orchid Healthcare Product and Services
2.13.5 Orchid Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Mylan Pharmaceuticals
2.14.1 Mylan Pharmaceuticals Details
2.14.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Mylan Pharmaceuticals SWOT Analysis
2.14.4 Mylan Pharmaceuticals Product and Services
2.14.5 Mylan Pharmaceuticals Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 F.Hoffmann La Roche
2.15.1 F.Hoffmann La Roche Details
2.15.2 F.Hoffmann La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 F.Hoffmann La Roche SWOT Analysis
2.15.4 F.Hoffmann La Roche Product and Services
2.15.5 F.Hoffmann La Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Mundipharma SWOT Analysis
2.16.4 Mundipharma Product and Services
2.16.5 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
6.4 France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7.5 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2015-2020)
11 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment by Application
11.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025)
12.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025)
12.2.4 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025)
12.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Type (2021-2025)
12.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 9. GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 12. GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Barr Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 15. Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Barr Laboratories SWOT Analysis
Table 17. Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 18. Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 21. Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck & Co SWOT Analysis
Table 23. Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 24. Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Helsinn Basic Information, Manufacturing Base and Competitors
Table 26. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 27. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Helsinn SWOT Analysis
Table 29. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 30. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Aphios Basic Information, Manufacturing Base and Competitors
Table 32. Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 33. Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Aphios SWOT Analysis
Table 35. Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 36. Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 38. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 39. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Heron Therapeutics SWOT Analysis
Table 41. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 42. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 45. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Eisai SWOT Analysis
Table 47. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 48. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Acacia Pharma Basic Information, Manufacturing Base and Competitors
Table 50. Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 51. Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Acacia Pharma SWOT Analysis
Table 53. Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 54. Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Tesaro Basic Information, Manufacturing Base and Competitors
Table 56. Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 57. Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Tesaro SWOT Analysis
Table 59. Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 60. Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 63. Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Baxter Healthcare SWOT Analysis
Table 65. Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 66. Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. OPKO Health Basic Information, Manufacturing Base and Competitors
Table 68. OPKO Health Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 69. OPKO Health Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 70. OPKO Health SWOT Analysis
Table 71. OPKO Health Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 72. OPKO Health Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Especificos Stendhal Basic Information, Manufacturing Base and Competitors
Table 74. Especificos Stendhal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 75. Especificos Stendhal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Especificos Stendhal SWOT Analysis
Table 77. Especificos Stendhal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 78. Especificos Stendhal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Orchid Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Orchid Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 81. Orchid Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Orchid Healthcare SWOT Analysis
Table 83. Orchid Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 84. Orchid Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Mylan Pharmaceuticals Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 87. Mylan Pharmaceuticals Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Mylan Pharmaceuticals SWOT Analysis
Table 89. Mylan Pharmaceuticals Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 90. Mylan Pharmaceuticals Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. F.Hoffmann La Roche Basic Information, Manufacturing Base and Competitors
Table 92. F.Hoffmann La Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 93. F.Hoffmann La Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 94. F.Hoffmann La Roche SWOT Analysis
Table 95. F.Hoffmann La Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 96. F.Hoffmann La Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 98. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Business
Table 99. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Mundipharma SWOT Analysis
Table 101. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 102. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 104. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Regions (2015-2020) (K Units)
Table 106. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Regions (2015-2020)
Table 107. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 108. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries (2015-2020) (K Units)
Table 109. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries (2015-2020)
Table 110. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020)
Table 112. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries (2015-2020) (K Units)
Table 113. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries (2015-2020)
Table 114. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Regions (2015-2020) (K Units)
Table 116. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 118. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries (2015-2020) (K Units)
Table 119. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries (2015-2020)
Table 120. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 121. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries (2015-2020) (K Units)
Table 123. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020)
Table 126. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2015-2020) (K Units)
Table 127. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2015-2020)
Table 128. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2015-2020) (USD Million)
Table 129. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2015-2020)
Table 130. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2015-2020) (K Units)
Table 131. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2015-2020)
Table 132. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 133. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Regions (2021-2025)
Table 134. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 135. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Type (2021-2025)
Table 136. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2021-2025)
Table 137. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Picture
Figure 2. Global Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type in 2019
Figure 3. Aloxi (palonosetron) Picture
Figure 4. Kytril Generic (granisetron) Picture
Figure 5. Emend (aprepitant) Picture
Figure 6. Akynzeo (netupitant-palonosetron) Picture
Figure 7. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2018
Figure 8. Blood Cancer Picture
Figure 9. Breast Cancer Picture
Figure 10. Gastrointestinal Tract Cancer Picture
Figure 11. Others Picture
Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries in 2018
Figure 49. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Regions 2019
Figure 65. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries in 2019
Figure 72. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
化学療法誘発性悪心嘔吐薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chemotherapy-induced Nausea and Vomiting Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 106.1 million by 2025, from USD 85 million in 2019…- オピオイド誘発性副作用治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Opioid Induced Side Effects Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 自己マトリックス誘発性軟骨形成の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Autologous Matrix-induced Chondrogenesis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 125.6 million by 2025, from USD 104.6 million in 2019. T…
- 化学療法誘発性末梢神経障害治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…
- 経口薄膜薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Thin Film Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2769.8 million by 2025, from USD 2033 million in 2019. The Oral Thin Film Dr…